Latest: FDA Approves New Biosimilar for Oncology Treatment

Higher tetrahydrocannabinol exposure may be associated with unfavorable mental health outcomes

0 Mins

1. In this systematic review, higher levels of tetrahydrocannabinol exposure were associated with multiple unfavorable mental health outcomes, particularly for psychosis or schizophrenia and cannabis use disorder. 2. Nearly half of studies involving therapeutic products did report favorable anxiety and depression outcomes, but studies in healthy persons generally reported unfavorable results. Evidence Rating Level: 1 […]

The post Higher tetrahydrocannabinol exposure may be associated with unfavorable mental health outcomes first appeared on 2 Minute Medicine.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago